Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults
- 20 December 2016
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 177 (1) , 212-222
Abstract
Background Linear IgA bullous dermatosis (LABD) is a clinically and immunologically heterogeneous, subepidermal, autoimmune bullous disease (AIBD), for which the long‐term evolution is poorly described. Objectives To investigate the clinical and immunological characteristics, follow‐up and prognostic factors of adult idiopathic LABD. Methods This retrospective study, conducted in our AIBD referral centre, included adults, diagnosed between 1995 and 2012, with idiopathic LABD, defined as pure or predominant IgA deposits by direct immunofluorescence. Clinical, histological and immunological findings were collected from charts. Standard histology was systematically reviewed, and indirect immunofluorescence (IIF) on salt‐split skin (SSS) and immunoblots (IBs) on amniotic membrane extracts using anti‐IgA secondary antibodies were performed, when biopsies and sera obtained at diagnosis were available. Prognostic factors for complete remission (CR) were identified using univariate and multivariate analyses. Results Of the 72 patients included (median age 54 years), 60% had mucous membrane (MM) involvement. IgA IIF on SSS was positive for 21 of 35 patients tested; 15 had epidermal and dermal labellings. Immunoelectron microscopy performed on the biopsies of 31 patients labelled lamina lucida (LL) (26%), lamina densa (23%), anchoring‐fibril zone (AFz) (19%) and LL+AFz (23%). Of the 34 IgA IBs, 22 were positive, mostly for LAD‐1/LABD97 (44%) and full‐length BP180 (33%). The median follow‐up was 39 months. Overall, 24 patients (36%) achieved sustained CR, 19 (29%) relapsed and 35% had chronic disease. CR was significantly associated with age > 70 years or no MM involvement. No prognostic immunological factor was identified. Conclusions Patients with LABD who are < 70 years old and have MM involvement are at risk for chronic evolution.Keywords
This publication has 67 references indexed in Scilit:
- Linear immunoglobulin A bullous dermatosisClinics in Dermatology, 2012
- Childhood Linear IgA Bullous Dermatosis in TunisiaPediatric Dermatology, 2009
- Linear IgA dermatosis: Report of an infantile case and analysis of 213 cases in JapanThe Journal of Dermatology, 2008
- Clinical and immunopathological heterogeneity of 22 cases of linear IgA bullous dermatosisJournal of the European Academy of Dermatology and Venereology, 2008
- Dermal-binding linear IgA disease: an uncommon subset of a rare immunobullous diseaseClinical and Experimental Dermatology, 2007
- A Case of Mixed Bullous Disease of Epidermolysis bullosa acquisita and Linear IgA Bullous DermatosisDermatology, 2005
- Unusual clinical manifestation of linear IgA dermatosis: A report of two casesJournal of the American Academy of Dermatology, 2004
- The 97kDa Linear IgA Bullous Disease Antigen Is Identical to a Portion of the Extracellular Domain of the 180kDa Bullous Pemphigoid Antigen, BPAg2Journal of Investigative Dermatology, 1998
- Linear IgA bullous dermatosis with autoantibodies to a 290 kd antigen of anchoring fibrilsJournal of the American Academy of Dermatology, 1994
- Vancomycin-associated linear IgA dermatosisJournal of the American Academy of Dermatology, 1992